| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Chief Scientific Officer | Director +1 more
2 companies
Ketchum Steven B is a Director at Viracta Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $865K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 316,604 | $16.13 | $5,105,588.80 | -22.0% | |
| Sep 25, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 879,241 | $11.10 | $9,760,023.88 | -30.0% | |
| Jan 23, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 135,205 | $4.41 | $596,429.82 | -48.8% | |
| Jan 11, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 2,612 | $4.40 | $11,492.80 | -1.8% | |
| Jan 5, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 64,683 | $4.40 | $284,631.07 | -31.3% | |
| Jan 2, 2018 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sale+OE | 128,257 | $4.25 | $545,092.25 | -47.5% | |
| Oct 5, 2017 | AMRN Amarin Corp Plc\uk | Chief Scientific Officer | Sell | 63,479 | $3.48 | $221,198.92 | -30.9% | |
| Jul 24, 2015 | VIRX Viracta Therapeutics, Inc. | Director | Sell | 6,358 | $3.46 | $21,989.14 | -3.7% |